Utility of brief questionnaires of health-related quality of life (Airways Questionnaire 20 and Clinical COPD Questionnaire) to predict exacerbations in patients with asthma and COPD

Health and Quality of Life Outcomes

Héctor Verea-Hernando³  Sonia Pértega-Diaz¹  Salvador Pita-Fernández¹  Isabel Vázquez²  Marina Blanco-Aparicio³ 

[1] Unidad de Epidemiología Clínica y Bioestadística, Complejo Hospitalario, Universitario A Coruña, A Coruña, Spain;Departamento de Psicología Clínica y Psicobiología, Facultad de Psicología, Universidad de Santiago de Compostela, Santiago de Compostela, Spain;Servicio de Neumología, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain

关键词: Health-related quality of life;    Hospitalization;    Emergency visits;    Risk factors;    Exacerbation;    Asthma;    COPD;   

Others  :  823653
DOI  :  10.1186/1477-7525-11-85

 received in 2012-11-06, accepted in 2013-05-21,  发布年份 2013

【 摘 要 】

Background

There is some evidence that quality of life measured by long disease-specific questionnaires may predict exacerbations in asthma and COPD, however brief quality of life tools, such as the Airways Questionnaire 20 (AQ20) or the Clinical COPD Questionnaire (CCQ), have not yet been evaluated as predictors of hospital exacerbations.

Objectives

To determine the ability of brief specific health-related quality of life (HRQoL) questionnaires (AQ20 and CCQ) to predict emergency department visits (ED) and hospitalizations in patients with asthma and COPD, and to compare them to longer disease-specific questionnaires, such as the St George´s Respiratory Questionnaire (SGRQ), the Chronic Respiratory Disease Questionnaire (CRQ) and the Asthma Quality of Life Questionnaire (AQLQ).

Methods

We conducted a two-year prospective cohort study of 208 adult patients (108 asthma, 100 COPD). Baseline sociodemographic, clinical, functional and psychological variables were assessed. All patients completed the AQ20 and the SGRQ. COPD patients also completed the CCQ and the CRQ, while asthmatic patients completed the AQLQ. We registered all exacerbations that required ED or hospitalizations in the follow-up period. Differences between groups (zero ED visits or hospitalizations versus ≥ 1 ED visits or hospitalizations) were tested with Pearson´s X² or Fisher´s exact test for categorical variables, ANOVA for normally distributed continuous variables, and Mann–Whitney U test for non-normally distributed variables. Logistic regression analyses were performed to estimate the predictive ability of each HRQoL questionnaire.

Results

In the first year of follow-up, the AQ20 scores predicted both ED visits (OR: 1.19; p = .004; AUC 0.723) and hospitalizations (OR: 1.21; p = .04; AUC 0.759) for asthma patients, and the CCQ emerged as independent predictor of ED visits in COPD patients (OR: 1.06; p = .036; AUC 0.651), after adjusting for sociodemographic, clinical, and psychological variables. Among the longer disease-specific questionnaires, only the AQLQ emerged as predictor of ED visits in asthma patients (OR: 0.9; p = .002; AUC 0.727). In the second year of follow-up, none of HRQoL questionnaires predicted exacerbations.

Conclusions

AQ20 predicts exacerbations in asthma and CCQ predicts ED visits in COPD in the first year of follow-up. Their predictive ability is similar to or even higher than that of longer disease-specific questionnaires.

【 授权许可】

   
2013 Blanco-Aparicio et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57:847-852.
• [2]Soler-Cataluña JJ, Martinez Garcia MA, Román Sanchez P, Salcedo E, Navarro M, Ochando R: Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005, 60:925-931.
• [3]Seemungal TA, Donaldson GC, Paul EA, Bestall JC: Jeffries D J, Wedzicha JA: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease . Am J Respir Crit Care Med 1998, 157(5 Pt 1):1418-1422.
• [4]Cydulka RK, Mcfadden ER, Emerman Ch L, Sivinski LD, Pisanelli WP, Rimm AD: Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997, 156(6):1807-1812.
• [5]Smith DH: A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997, 156:787-793.
• [6]Sullivan SD, Ramsey SD, Lee TA: The economic burden of COPD. Chest 2000, 117(Suppl):5S-9S.
• [7]Griswold SK, Nordstrom CR, Clark S, Gaeta TJ, Price ML, Camargo CA: Asthma exacerbations in North American adults: who are the “frequent fliers” in the emergency department? Chest 2005, 127(5):1579-1586.
• [8]Eisner MD, Katz PP, Lactao G, Iribarren C: Impact of depressive symptoms on adult asthma outcomes. Ann Allergy Asthma Immunol 2005, 94(5):566-574.
• [9]Garcia-Aymerich J, Monso E, Marrades RM, Escarrabill J, Felez MA, Sunyer J, Anto JM: Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med 2001, 164:1002-1007.
• [10]Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, Brondum E, Nieminen MM, Aine T, Bakke P: Risk factors for rehospitalization in COPD: role of health status, anxiety and depression. Eur Respir J 2005, 26:414-419.
• [11]Schatz M, Zeiger RS, Mosen D, Vollmer WM: Asthma specific quality of life and subsequent asthma emergency hospital care. Am J Manag Care 2008, 14(4):206-211.
• [12]Fan VS, Ramsey SD, Make BJ, Martinez FJ: Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. COPD 2007, 4:29-39.
• [13]Osman LM, Calder C, Robertson R, Friend JAR, Legge JS, Douglas JG: Symptoms, quality of life, and health service contact among young adults with mild asthma. Am J Respir Crit Care Med 2000, 161:498-503.
• [14]Eisner MD, Ackerson LM, Chi F, Kalkbrenner A, Buchner D, Mendoza G, Lieu T: Health-related quality of life and future health care utilization for asthma. Ann Allergy Asthma Immunol 2002, 89(1):46-55.
• [15]Quirk FH, Jones PW: Repeatability of two new short airways questionnaires. Thorax 1994, 49:1075.
• [16]Van der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF: Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes 2003, 1:13. BioMed Central Full Text
• [17]Schatz M, Mosen D, Apter AJ, Zeiger RS, Vollmer WM, Stibolt TB, Leong A, Johnson MS, Mendoza G, Cook EF: Relationship of validated psychometric tools to subsequent medical utilization for asthma. J Allergy Clin Immunol 2005, 115(3):564-570.
• [18]Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA, ACCP Workshop Panel on Anxiety and Depression in COPD: Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008, 134:43-56.
• [19]Balcells E, Gea J, Ferrer J, Serra I, Orozco-Levi M, Batlle J, Rodriguez E, Benet M, Donaire-González D, Antó JM, Garcia-Aymerich J, PAC-COPD Study Group: Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Outcomes 2010, 8:108. BioMed Central Full Text
• [20]Fabbri LM, Hurd SS: Global strategy for the diagnosis, management, and prevention of COPD: 2003 update. Eur Respir J 2003, 22:1-2.
• [21]Blanco-Aparicio M, Vázquez MI, Romero-Frais E, Seoane G, Verea-Hernando H: Validation of a Spanish version of the airways questionnaire 20: a short and simple instrument. Qual Life Res 2010, 19:1235-1240.
• [22]Hajiro T, Nishimura K, Jones PW, Tsukino M, Ikeda A, Koyama H, Izumi T: A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159:1874-1878.
• [23]Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M: Comparison of the responsiveness of different disease-specific health status measures in patients with asthma. Chest 2002, 122:1228-1233.
• [24]Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation: the St. George’s Respiratory Questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
• [25]Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987, 42:773-778.
• [26]Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK: Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992, 47:76-83.
• [27]Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE: Measuring quality of life in asthma. Am Rev Respir Dis 1993, 147:832-838.
• [28]Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Psychiatr Scand 1983, 76:361-370.
• [29]Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the Hospital anxiety and depression scale. An updated literature review. J Psychosom Res 2002, 52(2):69-77.
• [30]Blanco Aparicio M, Vázquez Rodriguez I, Verea Hernando H: Adaptación transcultural al español del “Airways Questionnaire 20 (AQ20): un cuestionario de calidad de vida abreviado para la evaluación clínica del asma y EPOC. Arch Bronconeumol 2009, 45(1):24-29.
• [31]Ferrer M, Alonso J, Prieto L, Plaza V, Monsó E, Marrades R, Aquar MC, Khalat A, Antó JM: Validity and reliability of the St. George´s Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J 1996, 9(6):1160-1166.
• [32]Güell R, Casan P, Sangenis M, Morante F, Belda J, Guyatt GH: Quality of life in patients with chronic respiratory disease: the Spanish version of the Chronic Respiratory Questionnaire (CRQ). Eur Respir J 1998, 11:55-60.
• [33]Sanjuás C, Alonso J, Sanchís J, Casan P, Broquetas JM, Ferrie PJ, Juniper EF, Antó JM: Cuestionario de calidad de vida en pacientes con asma: la versión española del Asthma Quality of Life Questionnaire. Arch Bronconeumol 1995, 31:219-224.
• [34]Blanco Aparicio M, Vázquez MI, Verea Hernando H: Fiabilidad y validez de la versión española del Clinical COPD Questionnaire (CCQ). Arch Bronconeumol 2010, 46:108s.
• [35]Caro I, Ibáñez E: La escala hospitalaria de ansiedad y depresión. Su utilización práctica en psicología de la salud. Bol Psicol 1992, 36:43-69.
• [36]Quintana JM, Padierna A, Esteban C, Arostegui I, Bilbao A, Ruiz I: Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 2003, 107:216-221.
• [37]Sanjuás C, Alonso J, Ferrer M, Currull V, Broquetas JM, Antó JM: Adaptation of the Asthma Quality of Life Questionnaire to a second language preserves its critical properties: The Spanish version. J Clin Epidemiol 2001, 54:182-189.
• [38]Butland RJA, Pang J, Gross ER, Woodcock M, Gedales DM: Two, six and twelve minute walking tests in respiratory disease. Br Med J 1982, 284:1607-1608.
• [39]Celli BR, MacNee W, Committee mambers: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946.
• [40]Win T, Pearce L, Nathan J, Mmath FC, Laroche C: Use of the Airway Questionnaire 20 to detect changes in quality of life in asthmatic patients and its association with the St George´s Respiratory Questionnaire and clinical parameters. Can Respir J 2008, 15(3):133-137.
• [41]Trappenburg JC, Touwen I, De Weert-van Oene GH, Bourbeau J, Monninkhof EM, Verheij TJ, Lammers JW, Schrijvers AJ: Detecting exacerbations using the Clinical COPD Questionnaire. Health Qual Life Outcomes 2010, 8:102. BioMed Central Full Text
• [42]Rodrigo GJ, Plaza V: Body mass index and response to emergency department treatment in adults with severe asthma exacerbations: a prospective cohort study. Chest 2007, 132(5):1513-1519.
• [43]Cao Z, Ong KC, Eng P, Tan WC, Ng TP: Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 2006, 11:188-195.
• [44]Li D, German D, Lulla S, Thomas RG, Wilson SR: Prospective study of hospitalization for asthma: a preliminary risk factor model. Am J Respir Crit Care Med 1995, 151(3 Pt 1):647-655.
• [45]Miller MK, Lee JH, Miller DP, Wenzel SE: Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 2007, 101(3):481-489.
• [46]Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova M, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA: Susceptibility to exacerbations in chronic obstructive pulmonary disease. N Engl J Med 2010, 363(12):1128-1138.
• [47]Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P: Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007, 167:60-67.
• [48]Naberan K, Azpeitia A, Cantoni J, Miravitlles M: Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir Med 2012, 106:367-373.
• [49]Vollmer WM, Markson LE, O´Connor E, Sanocki LL, Fitterman L, Berger M, Buist AS: Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 1999, 160:1647-1652.
• [50]Jones PW, Harding G, Berry P, Wiklund L, Chen W-H, Kline Leidy N: Development and first validation of the COPD assessment test. Eur Respir J 2009, 34:648-665.
• [51]Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 200. Updated 2011. [cited 2012 Sept 18]. Available from http://www.goldcopd.org/ webcite
• [52]Jones PW, Price D, van der Molen T: Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2011, 6:289-296.
• [53]Tsiligianni IG, van der Molen T, Moraitaki D, Lopez I, Kocks JWH, Karagiannis K, Siafakas N, Tzanakis N: Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med 2012, 12:20. BioMed Central Full Text
• [54]Kocks JWH, Tuinenga MG, Uil SM, van den Berg JWK, Stahl E, van der Molen T: Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res 2006, 7:62. BioMed Central Full Text
• [55]Kocks JWH, Kerstjens HAM, Snijders SL, De Vos B, Biermann JJ, Van Hengel P, Strijbos JH, Bosveld HEP, van der Molen T: Health status in routine clinical practice: validity of the clinical COPD questionnaire at the individual level. Health Qual Life Outcomes 2010, 8:135. BioMed Central Full Text
• [56]Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2013. cited 2013 Apr 23. Available from: http://www.goldcopd.org/ webcite
• [57]Jiménez-Ruiz CA, Sobradillo V, Gabriel R, Viejo JL, Masa JF, Miravitlles M, Villasante C, Fernández-Fau L: Respiratory symptoms and diagnosis of COPD in smokers of various types of tobacco. Results from the IBERPOC Study (in Spanish). Arch Bronconeumol 2002, 38:530-535.
• [58]Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, Verea H, Murio C, Ros F, Vidal R, IMPAC Study Group: Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004, 59:387-395.